Company Filing History:
2 out of 12 
2 out of 1,746 
1 out of 12 
Years Active: 2011-2013
Title: Nadja Patenge: Innovator in Neurodegenerative Disorder Research
Introduction
Nadja Patenge is a prominent inventor based in Rostock, Germany. She has made significant contributions to the field of neurodegenerative disorders through her innovative research and discoveries. With a total of two patents to her name, her work focuses on the detection and treatment of conditions such as Parkinson's disease and Alzheimer's disease.
Latest Patents
Nadja Patenge's latest patents include the KASPP (LRRK2) gene, which is crucial for the detection and treatment of neurodegenerative disorders. This invention refers to a newly discovered gene named KASPP, or Kinase Associated with Parkinsonism with Pleiomorphic Pathology, alternatively known as LRRK2, or Leucine-Rich Repeat Kinase 2. The patent details its production, biochemical characterization, and application in diagnosing and treating various neurodegenerative disorders, including sporadic Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and other related conditions.
Career Highlights
Throughout her career, Nadja Patenge has worked with esteemed institutions such as Eberhard Karls University Tuebingen and the Mayo Foundation for Medical Education and Research. Her research has significantly advanced the understanding of neurodegenerative diseases and their underlying genetic factors.
Collaborations
Nadja has collaborated with notable colleagues, including Thomas Meitinger and Tim Matthias Strom, contributing to a rich exchange of ideas and research in her field.
Conclusion
Nadja Patenge's innovative work in the realm of neurodegenerative disorders highlights her dedication to advancing medical science. Her discoveries, particularly regarding the KASPP (LRRK2) gene, have the potential to transform the diagnosis and treatment of these challenging conditions.